Correlation Between PYC Therapeutics and Rea

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PYC Therapeutics and Rea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PYC Therapeutics and Rea into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PYC Therapeutics and Rea Group, you can compare the effects of market volatilities on PYC Therapeutics and Rea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PYC Therapeutics with a short position of Rea. Check out your portfolio center. Please also check ongoing floating volatility patterns of PYC Therapeutics and Rea.

Diversification Opportunities for PYC Therapeutics and Rea

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between PYC and Rea is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding PYC Therapeutics and Rea Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rea Group and PYC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PYC Therapeutics are associated (or correlated) with Rea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rea Group has no effect on the direction of PYC Therapeutics i.e., PYC Therapeutics and Rea go up and down completely randomly.

Pair Corralation between PYC Therapeutics and Rea

Assuming the 90 days trading horizon PYC Therapeutics is expected to under-perform the Rea. In addition to that, PYC Therapeutics is 2.24 times more volatile than Rea Group. It trades about -0.29 of its total potential returns per unit of risk. Rea Group is currently generating about 0.04 per unit of volatility. If you would invest  23,716  in Rea Group on October 15, 2024 and sell it today you would earn a total of  218.00  from holding Rea Group or generate 0.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PYC Therapeutics  vs.  Rea Group

 Performance 
       Timeline  
PYC Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PYC Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Rea Group 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Rea Group are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Rea may actually be approaching a critical reversion point that can send shares even higher in February 2025.

PYC Therapeutics and Rea Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PYC Therapeutics and Rea

The main advantage of trading using opposite PYC Therapeutics and Rea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PYC Therapeutics position performs unexpectedly, Rea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rea will offset losses from the drop in Rea's long position.
The idea behind PYC Therapeutics and Rea Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets